.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AX01_Azathioprine.Azathioprine .Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AX01_Azathioprine.Azathioprine| name: | Azathioprine |
| ATC code: | L04AX01 | route: | oral |
| n-compartments | 1 |
Azathioprine is an immunosuppressive antimetabolite used to prevent organ transplant rejection and to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. It is an approved drug still in clinical use.
Pharmacokinetic parameters in healthy adult subjects after a single oral dose.
Rosenbaum, SE, et al., & Akhlaghi, F (2005). Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients. Therapeutic drug monitoring 27(2) 116–122. DOI:10.1097/01.ftd.0000148448.51225.2c PUBMED:https://pubmed.ncbi.nlm.nih.gov/15795639
Ettenger, RB, & Grimm, EM (2001). Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation 38(4 Suppl 2) S22–S28. DOI:10.1053/ajkd.2001.27838 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11583941
Dirks, NL, et al., & Meibohm, B (2004). Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. International journal of clinical pharmacology and therapeutics 42(12) 701–718. DOI:10.5414/cpp42701 PUBMED:https://pubmed.ncbi.nlm.nih.gov/15624287